D. Bolognini

发表

Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect

E. Monti, M. Gariboldi, M. Solinas, 2013, PloS one.

Investigations on the 4‐Quinolone‐3‐Carboxylic Acid Motif Part 5: Modulation of the Physicochemical Profile of a Set of Potent and Selective Cannabinoid‐2 Receptor Ligands through a Bioisosteric Approach

M. Cascio, D. Bolognini, R. Pertwee, 2012, ChemMedChem.

CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity

D. Bolognini, S. McAllister, R. Pertwee, 2013, Molecular Pharmacology.

Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus

P. Fletcher, M. Cascio, D. Bolognini, 2012, British journal of pharmacology.

Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates

D. Bolognini, D. Rigamonti, E. Cattaneo, 2010, BMC Neuroscience.

The plant cannabinoid Δ9‐tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice

M. Cascio, D. Bolognini, D. Parolaro, 2010, British journal of pharmacology.

AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor

M. Cascio, D. Bolognini, D. Parolaro, 2012, British journal of pharmacology.

THEMED ISSUE: CANNABINOIDS RESEARCH PAPER The plant cannabinoid D 9 -tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice

M. Cascio, D. Bolognini, D. Parolaro, 2010 .

Pharmacological properties of the phytocannabinoids Δ9-tetrahydrocannabivarin and cannabidiol.

D. Bolognini, 2010 .

Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors.

M. Cascio, D. Bolognini, M. D. De Rosa, 2012, European journal of medicinal chemistry.

Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands.

M. Cascio, D. Bolognini, M. D. De Rosa, 2010, Journal of medicinal chemistry.

In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists.

M. Cascio, D. Bolognini, V. Di Marzo, 2010, Pharmacological research.

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84

S. McMahon, G. Milligan, A. Tobin, 2019, Scientific Reports.

CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency

M. Cascio, D. Bolognini, R. Smoum, 2015, Proceedings of the National Academy of Sciences.

The Pharmacology and Function of Receptors for Short-Chain Fatty Acids

G. Milligan, A. Tobin, D. Bolognini, 2016, Molecular Pharmacology.

A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias*

Ashley M. Miller, G. Milligan, A. Tobin, 2016, The Journal of Biological Chemistry.

Chemogenetics defines receptor-mediated functions of short chain free fatty acids

B. Hudson, G. Milligan, A. Tobin, 2019, Nature Chemical Biology.

Metabolic and inflammatory functions of short-chain fatty acid receptors

G. Milligan, D. Bolognini, Domonkos Dedeo, 2020, Current Opinion in Endocrine and Metabolic Research.

Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.

C. Quince, R. Klopfleisch, U. Ijaz, 2019, Gastroenterology.

Chemogenetics defines a short-chain fatty acid receptor gut–brain axis

J. Riddell, B. Hudson, A. Tobin, 2022, eLife.

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea‐induced behaviour in rats by enhancing 5‐HT1A receptor activation

M. Cascio, D. Bolognini, C. Limebeer, 2013, British journal of pharmacology.

Loss of Huntingtin Function Complemented by Small Molecules Acting as Repressor Element 1/Neuron Restrictive Silencer Element Silencer Modulators*

D. Bolognini, F. Sola, D. Rigamonti, 2007, Journal of Biological Chemistry.

Medical cannabis vs. synthetic cannabinoids: What does the future hold?

D. Bolognini, R. Ross, 2015, Clinical pharmacology and therapy.

Chemogenetic analysis of how receptors for short chain fatty acids regulate the gut-brain axis

J. Riddell, B. Hudson, G. Milligan, 2020, bioRxiv.

Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties.

Christer S. Ejsing, G. Milligan, D. Bolognini, 2018, Journal of medicinal chemistry.

Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist.

C. Breivogel, M. Cascio, D. Bolognini, 2011, European journal of pharmacology.

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84

S. McMahon, G. Milligan, A. Tobin, 2019, Scientific Reports.

Setting the conditions for efficient, robust and reproducible generation of functionally active neurons from adult subventricular zone-derived neural stem cells

G. Biella, D. Bolognini, I. Biunno, 2008, Cell Death and Differentiation.

A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias

B. Hudson, G. Milligan, D. Bolognini, 2017, Scientific Reports.

Ligands at the Free Fatty Acid Receptors 2/3 (GPR43/GPR41).

G. Milligan, D. Bolognini, E. Sergeev, 2017, Handbook of experimental pharmacology.

Expression and function of the endocannabinoid system in glial cells.

P. Massi, M. Valenti, D. Bolognini, 2008, Current pharmaceutical design.

The Pharmacology and Function of Receptors for Short-Chain Fatty Acids

G. Milligan, A. Tobin, D. Bolognini, 2016, Molecular Pharmacology.

Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.

C. Quince, R. Klopfleisch, U. Ijaz, 2019, Gastroenterology.

Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties.

Christer S. Ejsing, G. Milligan, D. Bolognini, 2018, Journal of medicinal chemistry.

P273 Chemogenetic analysis of how receptors for short chain fatty acids regulate the gut-brain axis

B. Hudson, G. Milligan, A. Tobin, 2021, Posters.

Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner

D. Bolognini, Sara Marsango, Falko Nagel, 2023, bioRxiv.

THEMED ISSUE: CANNABINOIDS RESEARCH PAPER The plant cannabinoid D-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in micebph_756 677..687

M. Cascio, D. Bolognini, D. Parolaro, 2010 .

Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus

M. Cascio, D. Bolognini, C. Limebeer, 2012, British journal of pharmacology.